PHYTOTHER RES 润色咨询

PHYTOTHERAPY RESEARCH

出版年份:1987 年文章数:3253 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:12.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2198860, encodeId=1f2b219886031, content=请问接收后大概多长时间见刊呀?都两个半月了,还没任何动静。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c045428867, createdName=ms6000001777595875, createdTime=Tue Apr 16 21:26:35 CST 2024, time=2024-04-16, status=1, ipAttribution=孟加拉), GetPortalCommentsPageByObjectIdResponse(id=2199397, encodeId=1ebd219939eb5, content=审稿速度:24.0<br>经验分享:垃圾期刊,没有之一。投了七个多月了,没有任何消息,催搞也不回信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f32309374, createdName=1222328fm20(暂无昵称), createdTime=Sat Apr 20 00:04:12 CST 2024, time=2024-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195236, encodeId=d2ba21952361c, content=我想问一下大家编辑的31条意见应该怎么回复啊,需要每条很仔细的回复吗?还是应该怎么回复啊··, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=27625535846, createdName=ms4000001250091268, createdTime=Mon Mar 25 15:18:41 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126735, encodeId=79ad2126e355b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:感觉杂志水平很好,投稿过程较顺利,投稿1个月后大修,补实验1个月,提交后1个月后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf345468059, createdName=王明强, createdTime=Tue Apr 18 13:19:28 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184848, encodeId=352621848482f, content=请问in production状态消失了,还没有收到proof,也没有DIO号,后面还有啥流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b73f6470340, createdName=ms4000000369825251, createdTime=Tue Jan 30 16:54:01 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2127833, encodeId=4617212e8331b, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药;神经<br>经验分享:历时四个月左右文章才接受。之前投其他被拒绝了就不算了,真是漫长啊。幸运的是还好赶在了毕业答辩前。这个期刊发文量低得很,审稿漫长,大家着急的就不要投了。<br>提交3天后这个PHYTOTHER RES就under review 后来两个月零20多天吧才给我一审结果,还好是小修,总共3个审稿人。开心的是第二个审稿人夸我,说我做得好,肯定了我的工作。修回后过了20天,二审结果又是小修,但是没有意见,我懵了,只有第一审稿人说我回答的不错。发邮件问还有意见吗也不回我,害我白白等了10天多。后来自己随便改了下,一点点。第二天就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms亦菲, createdTime=Sun Apr 23 14:47:39 CST 2023, time=2023-04-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2160190, encodeId=1b8121601900c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:单体<br>经验分享:05-Mar-2023 投稿<br>08-Mar-2023 Under review(此under review是指送审)<br>15-Apr-2023 大修;5个审稿人,然后editor会统一发31条意见(40天,30个工作日,一审回来,此期刊不管大修还是小修都是3个月)<br>12-Jul-2023返修回去(中间经历毕业答辩,考试,所以花了3个月时间,但是如果修改的快的话,是不需要这么久的)<br>20-Aug-2023 小修意见回来(一个月左右),一个问题+润色,语言要求较高,会推荐wiley edit润色服务,但我没润色)<br>08-Sep-2023意见回来(因为上面叫润色,没润,然后老老实实润色)<br>润色完,返修回去,第二天接受<br>总体来说,期刊友好,审稿和送审速度都还行,审稿严谨仔细(包括参考文献都会仔细检查是否引用正确),wb结果审稿人会要求提供,可OA与非OA,物美价廉,是个不错的期刊。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b518121154, createdName=科研民工@, createdTime=Thu Sep 28 14:39:47 CST 2023, time=2023-09-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140923, encodeId=e1c62140923b4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:08-Nov-2022提交;17-Feb-2023返回大修;期间两次小修;Accept (03-Jun-2023)。4个审稿人,1个编辑(第二个高级编辑)提问。对语言要求较高,小修都是语言润色,建议提前润色可以缩短1-2个月审稿时间。杂志水平挺不错的,严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec4f6416632, createdName=ms8000000153643625, createdTime=Mon Jun 05 17:23:46 CST 2023, time=2023-06-05, status=1, ipAttribution=山西省)]
    2024-04-16 ms6000001777595875 来自孟加拉

    请问接收后大概多长时间见刊呀?都两个半月了,还没任何动静。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2198860, encodeId=1f2b219886031, content=请问接收后大概多长时间见刊呀?都两个半月了,还没任何动静。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c045428867, createdName=ms6000001777595875, createdTime=Tue Apr 16 21:26:35 CST 2024, time=2024-04-16, status=1, ipAttribution=孟加拉), GetPortalCommentsPageByObjectIdResponse(id=2199397, encodeId=1ebd219939eb5, content=审稿速度:24.0<br>经验分享:垃圾期刊,没有之一。投了七个多月了,没有任何消息,催搞也不回信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f32309374, createdName=1222328fm20(暂无昵称), createdTime=Sat Apr 20 00:04:12 CST 2024, time=2024-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195236, encodeId=d2ba21952361c, content=我想问一下大家编辑的31条意见应该怎么回复啊,需要每条很仔细的回复吗?还是应该怎么回复啊··, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=27625535846, createdName=ms4000001250091268, createdTime=Mon Mar 25 15:18:41 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126735, encodeId=79ad2126e355b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:感觉杂志水平很好,投稿过程较顺利,投稿1个月后大修,补实验1个月,提交后1个月后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf345468059, createdName=王明强, createdTime=Tue Apr 18 13:19:28 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184848, encodeId=352621848482f, content=请问in production状态消失了,还没有收到proof,也没有DIO号,后面还有啥流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b73f6470340, createdName=ms4000000369825251, createdTime=Tue Jan 30 16:54:01 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2127833, encodeId=4617212e8331b, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药;神经<br>经验分享:历时四个月左右文章才接受。之前投其他被拒绝了就不算了,真是漫长啊。幸运的是还好赶在了毕业答辩前。这个期刊发文量低得很,审稿漫长,大家着急的就不要投了。<br>提交3天后这个PHYTOTHER RES就under review 后来两个月零20多天吧才给我一审结果,还好是小修,总共3个审稿人。开心的是第二个审稿人夸我,说我做得好,肯定了我的工作。修回后过了20天,二审结果又是小修,但是没有意见,我懵了,只有第一审稿人说我回答的不错。发邮件问还有意见吗也不回我,害我白白等了10天多。后来自己随便改了下,一点点。第二天就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms亦菲, createdTime=Sun Apr 23 14:47:39 CST 2023, time=2023-04-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2160190, encodeId=1b8121601900c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:单体<br>经验分享:05-Mar-2023 投稿<br>08-Mar-2023 Under review(此under review是指送审)<br>15-Apr-2023 大修;5个审稿人,然后editor会统一发31条意见(40天,30个工作日,一审回来,此期刊不管大修还是小修都是3个月)<br>12-Jul-2023返修回去(中间经历毕业答辩,考试,所以花了3个月时间,但是如果修改的快的话,是不需要这么久的)<br>20-Aug-2023 小修意见回来(一个月左右),一个问题+润色,语言要求较高,会推荐wiley edit润色服务,但我没润色)<br>08-Sep-2023意见回来(因为上面叫润色,没润,然后老老实实润色)<br>润色完,返修回去,第二天接受<br>总体来说,期刊友好,审稿和送审速度都还行,审稿严谨仔细(包括参考文献都会仔细检查是否引用正确),wb结果审稿人会要求提供,可OA与非OA,物美价廉,是个不错的期刊。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b518121154, createdName=科研民工@, createdTime=Thu Sep 28 14:39:47 CST 2023, time=2023-09-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140923, encodeId=e1c62140923b4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:08-Nov-2022提交;17-Feb-2023返回大修;期间两次小修;Accept (03-Jun-2023)。4个审稿人,1个编辑(第二个高级编辑)提问。对语言要求较高,小修都是语言润色,建议提前润色可以缩短1-2个月审稿时间。杂志水平挺不错的,严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec4f6416632, createdName=ms8000000153643625, createdTime=Mon Jun 05 17:23:46 CST 2023, time=2023-06-05, status=1, ipAttribution=山西省)]
    2024-04-20 1222328fm20(暂无昵称) 来自广东省

    审稿速度:24.0
    经验分享:垃圾期刊,没有之一。投了七个多月了,没有任何消息,催搞也不回信。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2198860, encodeId=1f2b219886031, content=请问接收后大概多长时间见刊呀?都两个半月了,还没任何动静。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c045428867, createdName=ms6000001777595875, createdTime=Tue Apr 16 21:26:35 CST 2024, time=2024-04-16, status=1, ipAttribution=孟加拉), GetPortalCommentsPageByObjectIdResponse(id=2199397, encodeId=1ebd219939eb5, content=审稿速度:24.0<br>经验分享:垃圾期刊,没有之一。投了七个多月了,没有任何消息,催搞也不回信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f32309374, createdName=1222328fm20(暂无昵称), createdTime=Sat Apr 20 00:04:12 CST 2024, time=2024-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195236, encodeId=d2ba21952361c, content=我想问一下大家编辑的31条意见应该怎么回复啊,需要每条很仔细的回复吗?还是应该怎么回复啊··, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=27625535846, createdName=ms4000001250091268, createdTime=Mon Mar 25 15:18:41 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126735, encodeId=79ad2126e355b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:感觉杂志水平很好,投稿过程较顺利,投稿1个月后大修,补实验1个月,提交后1个月后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf345468059, createdName=王明强, createdTime=Tue Apr 18 13:19:28 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184848, encodeId=352621848482f, content=请问in production状态消失了,还没有收到proof,也没有DIO号,后面还有啥流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b73f6470340, createdName=ms4000000369825251, createdTime=Tue Jan 30 16:54:01 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2127833, encodeId=4617212e8331b, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药;神经<br>经验分享:历时四个月左右文章才接受。之前投其他被拒绝了就不算了,真是漫长啊。幸运的是还好赶在了毕业答辩前。这个期刊发文量低得很,审稿漫长,大家着急的就不要投了。<br>提交3天后这个PHYTOTHER RES就under review 后来两个月零20多天吧才给我一审结果,还好是小修,总共3个审稿人。开心的是第二个审稿人夸我,说我做得好,肯定了我的工作。修回后过了20天,二审结果又是小修,但是没有意见,我懵了,只有第一审稿人说我回答的不错。发邮件问还有意见吗也不回我,害我白白等了10天多。后来自己随便改了下,一点点。第二天就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms亦菲, createdTime=Sun Apr 23 14:47:39 CST 2023, time=2023-04-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2160190, encodeId=1b8121601900c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:单体<br>经验分享:05-Mar-2023 投稿<br>08-Mar-2023 Under review(此under review是指送审)<br>15-Apr-2023 大修;5个审稿人,然后editor会统一发31条意见(40天,30个工作日,一审回来,此期刊不管大修还是小修都是3个月)<br>12-Jul-2023返修回去(中间经历毕业答辩,考试,所以花了3个月时间,但是如果修改的快的话,是不需要这么久的)<br>20-Aug-2023 小修意见回来(一个月左右),一个问题+润色,语言要求较高,会推荐wiley edit润色服务,但我没润色)<br>08-Sep-2023意见回来(因为上面叫润色,没润,然后老老实实润色)<br>润色完,返修回去,第二天接受<br>总体来说,期刊友好,审稿和送审速度都还行,审稿严谨仔细(包括参考文献都会仔细检查是否引用正确),wb结果审稿人会要求提供,可OA与非OA,物美价廉,是个不错的期刊。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b518121154, createdName=科研民工@, createdTime=Thu Sep 28 14:39:47 CST 2023, time=2023-09-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140923, encodeId=e1c62140923b4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:08-Nov-2022提交;17-Feb-2023返回大修;期间两次小修;Accept (03-Jun-2023)。4个审稿人,1个编辑(第二个高级编辑)提问。对语言要求较高,小修都是语言润色,建议提前润色可以缩短1-2个月审稿时间。杂志水平挺不错的,严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec4f6416632, createdName=ms8000000153643625, createdTime=Mon Jun 05 17:23:46 CST 2023, time=2023-06-05, status=1, ipAttribution=山西省)]
    2024-03-25 ms4000001250091268 来自浙江省

    我想问一下大家编辑的31条意见应该怎么回复啊,需要每条很仔细的回复吗?还是应该怎么回复啊··

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2198860, encodeId=1f2b219886031, content=请问接收后大概多长时间见刊呀?都两个半月了,还没任何动静。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c045428867, createdName=ms6000001777595875, createdTime=Tue Apr 16 21:26:35 CST 2024, time=2024-04-16, status=1, ipAttribution=孟加拉), GetPortalCommentsPageByObjectIdResponse(id=2199397, encodeId=1ebd219939eb5, content=审稿速度:24.0<br>经验分享:垃圾期刊,没有之一。投了七个多月了,没有任何消息,催搞也不回信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f32309374, createdName=1222328fm20(暂无昵称), createdTime=Sat Apr 20 00:04:12 CST 2024, time=2024-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195236, encodeId=d2ba21952361c, content=我想问一下大家编辑的31条意见应该怎么回复啊,需要每条很仔细的回复吗?还是应该怎么回复啊··, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=27625535846, createdName=ms4000001250091268, createdTime=Mon Mar 25 15:18:41 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126735, encodeId=79ad2126e355b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:感觉杂志水平很好,投稿过程较顺利,投稿1个月后大修,补实验1个月,提交后1个月后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf345468059, createdName=王明强, createdTime=Tue Apr 18 13:19:28 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184848, encodeId=352621848482f, content=请问in production状态消失了,还没有收到proof,也没有DIO号,后面还有啥流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b73f6470340, createdName=ms4000000369825251, createdTime=Tue Jan 30 16:54:01 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2127833, encodeId=4617212e8331b, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药;神经<br>经验分享:历时四个月左右文章才接受。之前投其他被拒绝了就不算了,真是漫长啊。幸运的是还好赶在了毕业答辩前。这个期刊发文量低得很,审稿漫长,大家着急的就不要投了。<br>提交3天后这个PHYTOTHER RES就under review 后来两个月零20多天吧才给我一审结果,还好是小修,总共3个审稿人。开心的是第二个审稿人夸我,说我做得好,肯定了我的工作。修回后过了20天,二审结果又是小修,但是没有意见,我懵了,只有第一审稿人说我回答的不错。发邮件问还有意见吗也不回我,害我白白等了10天多。后来自己随便改了下,一点点。第二天就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms亦菲, createdTime=Sun Apr 23 14:47:39 CST 2023, time=2023-04-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2160190, encodeId=1b8121601900c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:单体<br>经验分享:05-Mar-2023 投稿<br>08-Mar-2023 Under review(此under review是指送审)<br>15-Apr-2023 大修;5个审稿人,然后editor会统一发31条意见(40天,30个工作日,一审回来,此期刊不管大修还是小修都是3个月)<br>12-Jul-2023返修回去(中间经历毕业答辩,考试,所以花了3个月时间,但是如果修改的快的话,是不需要这么久的)<br>20-Aug-2023 小修意见回来(一个月左右),一个问题+润色,语言要求较高,会推荐wiley edit润色服务,但我没润色)<br>08-Sep-2023意见回来(因为上面叫润色,没润,然后老老实实润色)<br>润色完,返修回去,第二天接受<br>总体来说,期刊友好,审稿和送审速度都还行,审稿严谨仔细(包括参考文献都会仔细检查是否引用正确),wb结果审稿人会要求提供,可OA与非OA,物美价廉,是个不错的期刊。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b518121154, createdName=科研民工@, createdTime=Thu Sep 28 14:39:47 CST 2023, time=2023-09-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140923, encodeId=e1c62140923b4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:08-Nov-2022提交;17-Feb-2023返回大修;期间两次小修;Accept (03-Jun-2023)。4个审稿人,1个编辑(第二个高级编辑)提问。对语言要求较高,小修都是语言润色,建议提前润色可以缩短1-2个月审稿时间。杂志水平挺不错的,严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec4f6416632, createdName=ms8000000153643625, createdTime=Mon Jun 05 17:23:46 CST 2023, time=2023-06-05, status=1, ipAttribution=山西省)]
    2023-04-18 王明强 来自广东省

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:感觉杂志水平很好,投稿过程较顺利,投稿1个月后大修,补实验1个月,提交后1个月后接受

    13

    展开13条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2198860, encodeId=1f2b219886031, content=请问接收后大概多长时间见刊呀?都两个半月了,还没任何动静。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c045428867, createdName=ms6000001777595875, createdTime=Tue Apr 16 21:26:35 CST 2024, time=2024-04-16, status=1, ipAttribution=孟加拉), GetPortalCommentsPageByObjectIdResponse(id=2199397, encodeId=1ebd219939eb5, content=审稿速度:24.0<br>经验分享:垃圾期刊,没有之一。投了七个多月了,没有任何消息,催搞也不回信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f32309374, createdName=1222328fm20(暂无昵称), createdTime=Sat Apr 20 00:04:12 CST 2024, time=2024-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195236, encodeId=d2ba21952361c, content=我想问一下大家编辑的31条意见应该怎么回复啊,需要每条很仔细的回复吗?还是应该怎么回复啊··, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=27625535846, createdName=ms4000001250091268, createdTime=Mon Mar 25 15:18:41 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126735, encodeId=79ad2126e355b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:感觉杂志水平很好,投稿过程较顺利,投稿1个月后大修,补实验1个月,提交后1个月后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf345468059, createdName=王明强, createdTime=Tue Apr 18 13:19:28 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184848, encodeId=352621848482f, content=请问in production状态消失了,还没有收到proof,也没有DIO号,后面还有啥流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b73f6470340, createdName=ms4000000369825251, createdTime=Tue Jan 30 16:54:01 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2127833, encodeId=4617212e8331b, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药;神经<br>经验分享:历时四个月左右文章才接受。之前投其他被拒绝了就不算了,真是漫长啊。幸运的是还好赶在了毕业答辩前。这个期刊发文量低得很,审稿漫长,大家着急的就不要投了。<br>提交3天后这个PHYTOTHER RES就under review 后来两个月零20多天吧才给我一审结果,还好是小修,总共3个审稿人。开心的是第二个审稿人夸我,说我做得好,肯定了我的工作。修回后过了20天,二审结果又是小修,但是没有意见,我懵了,只有第一审稿人说我回答的不错。发邮件问还有意见吗也不回我,害我白白等了10天多。后来自己随便改了下,一点点。第二天就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms亦菲, createdTime=Sun Apr 23 14:47:39 CST 2023, time=2023-04-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2160190, encodeId=1b8121601900c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:单体<br>经验分享:05-Mar-2023 投稿<br>08-Mar-2023 Under review(此under review是指送审)<br>15-Apr-2023 大修;5个审稿人,然后editor会统一发31条意见(40天,30个工作日,一审回来,此期刊不管大修还是小修都是3个月)<br>12-Jul-2023返修回去(中间经历毕业答辩,考试,所以花了3个月时间,但是如果修改的快的话,是不需要这么久的)<br>20-Aug-2023 小修意见回来(一个月左右),一个问题+润色,语言要求较高,会推荐wiley edit润色服务,但我没润色)<br>08-Sep-2023意见回来(因为上面叫润色,没润,然后老老实实润色)<br>润色完,返修回去,第二天接受<br>总体来说,期刊友好,审稿和送审速度都还行,审稿严谨仔细(包括参考文献都会仔细检查是否引用正确),wb结果审稿人会要求提供,可OA与非OA,物美价廉,是个不错的期刊。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b518121154, createdName=科研民工@, createdTime=Thu Sep 28 14:39:47 CST 2023, time=2023-09-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140923, encodeId=e1c62140923b4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:08-Nov-2022提交;17-Feb-2023返回大修;期间两次小修;Accept (03-Jun-2023)。4个审稿人,1个编辑(第二个高级编辑)提问。对语言要求较高,小修都是语言润色,建议提前润色可以缩短1-2个月审稿时间。杂志水平挺不错的,严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec4f6416632, createdName=ms8000000153643625, createdTime=Mon Jun 05 17:23:46 CST 2023, time=2023-06-05, status=1, ipAttribution=山西省)]
    2024-01-30 ms4000000369825251 来自上海

    请问in production状态消失了,还没有收到proof,也没有DIO号,后面还有啥流程呀

    7

    展开7条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2198860, encodeId=1f2b219886031, content=请问接收后大概多长时间见刊呀?都两个半月了,还没任何动静。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c045428867, createdName=ms6000001777595875, createdTime=Tue Apr 16 21:26:35 CST 2024, time=2024-04-16, status=1, ipAttribution=孟加拉), GetPortalCommentsPageByObjectIdResponse(id=2199397, encodeId=1ebd219939eb5, content=审稿速度:24.0<br>经验分享:垃圾期刊,没有之一。投了七个多月了,没有任何消息,催搞也不回信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f32309374, createdName=1222328fm20(暂无昵称), createdTime=Sat Apr 20 00:04:12 CST 2024, time=2024-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195236, encodeId=d2ba21952361c, content=我想问一下大家编辑的31条意见应该怎么回复啊,需要每条很仔细的回复吗?还是应该怎么回复啊··, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=27625535846, createdName=ms4000001250091268, createdTime=Mon Mar 25 15:18:41 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126735, encodeId=79ad2126e355b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:感觉杂志水平很好,投稿过程较顺利,投稿1个月后大修,补实验1个月,提交后1个月后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf345468059, createdName=王明强, createdTime=Tue Apr 18 13:19:28 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184848, encodeId=352621848482f, content=请问in production状态消失了,还没有收到proof,也没有DIO号,后面还有啥流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b73f6470340, createdName=ms4000000369825251, createdTime=Tue Jan 30 16:54:01 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2127833, encodeId=4617212e8331b, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药;神经<br>经验分享:历时四个月左右文章才接受。之前投其他被拒绝了就不算了,真是漫长啊。幸运的是还好赶在了毕业答辩前。这个期刊发文量低得很,审稿漫长,大家着急的就不要投了。<br>提交3天后这个PHYTOTHER RES就under review 后来两个月零20多天吧才给我一审结果,还好是小修,总共3个审稿人。开心的是第二个审稿人夸我,说我做得好,肯定了我的工作。修回后过了20天,二审结果又是小修,但是没有意见,我懵了,只有第一审稿人说我回答的不错。发邮件问还有意见吗也不回我,害我白白等了10天多。后来自己随便改了下,一点点。第二天就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms亦菲, createdTime=Sun Apr 23 14:47:39 CST 2023, time=2023-04-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2160190, encodeId=1b8121601900c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:单体<br>经验分享:05-Mar-2023 投稿<br>08-Mar-2023 Under review(此under review是指送审)<br>15-Apr-2023 大修;5个审稿人,然后editor会统一发31条意见(40天,30个工作日,一审回来,此期刊不管大修还是小修都是3个月)<br>12-Jul-2023返修回去(中间经历毕业答辩,考试,所以花了3个月时间,但是如果修改的快的话,是不需要这么久的)<br>20-Aug-2023 小修意见回来(一个月左右),一个问题+润色,语言要求较高,会推荐wiley edit润色服务,但我没润色)<br>08-Sep-2023意见回来(因为上面叫润色,没润,然后老老实实润色)<br>润色完,返修回去,第二天接受<br>总体来说,期刊友好,审稿和送审速度都还行,审稿严谨仔细(包括参考文献都会仔细检查是否引用正确),wb结果审稿人会要求提供,可OA与非OA,物美价廉,是个不错的期刊。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b518121154, createdName=科研民工@, createdTime=Thu Sep 28 14:39:47 CST 2023, time=2023-09-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140923, encodeId=e1c62140923b4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:08-Nov-2022提交;17-Feb-2023返回大修;期间两次小修;Accept (03-Jun-2023)。4个审稿人,1个编辑(第二个高级编辑)提问。对语言要求较高,小修都是语言润色,建议提前润色可以缩短1-2个月审稿时间。杂志水平挺不错的,严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec4f6416632, createdName=ms8000000153643625, createdTime=Mon Jun 05 17:23:46 CST 2023, time=2023-06-05, status=1, ipAttribution=山西省)]
    2024-03-01 ms6000001594127539 来自伦敦

    审稿速度:6.0 | 投稿命中率:25.0
    偏重的研究方向:肿瘤;天然产物;综述
    经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。
    初次提交:20230901;
    审稿意见返回,给了三个月的时间大修:20231120;
    返修回去,送回审稿人:20240208;
    一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;
    二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;
    接收:20240229。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2198860, encodeId=1f2b219886031, content=请问接收后大概多长时间见刊呀?都两个半月了,还没任何动静。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c045428867, createdName=ms6000001777595875, createdTime=Tue Apr 16 21:26:35 CST 2024, time=2024-04-16, status=1, ipAttribution=孟加拉), GetPortalCommentsPageByObjectIdResponse(id=2199397, encodeId=1ebd219939eb5, content=审稿速度:24.0<br>经验分享:垃圾期刊,没有之一。投了七个多月了,没有任何消息,催搞也不回信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f32309374, createdName=1222328fm20(暂无昵称), createdTime=Sat Apr 20 00:04:12 CST 2024, time=2024-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195236, encodeId=d2ba21952361c, content=我想问一下大家编辑的31条意见应该怎么回复啊,需要每条很仔细的回复吗?还是应该怎么回复啊··, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=27625535846, createdName=ms4000001250091268, createdTime=Mon Mar 25 15:18:41 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126735, encodeId=79ad2126e355b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:感觉杂志水平很好,投稿过程较顺利,投稿1个月后大修,补实验1个月,提交后1个月后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf345468059, createdName=王明强, createdTime=Tue Apr 18 13:19:28 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184848, encodeId=352621848482f, content=请问in production状态消失了,还没有收到proof,也没有DIO号,后面还有啥流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b73f6470340, createdName=ms4000000369825251, createdTime=Tue Jan 30 16:54:01 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2127833, encodeId=4617212e8331b, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药;神经<br>经验分享:历时四个月左右文章才接受。之前投其他被拒绝了就不算了,真是漫长啊。幸运的是还好赶在了毕业答辩前。这个期刊发文量低得很,审稿漫长,大家着急的就不要投了。<br>提交3天后这个PHYTOTHER RES就under review 后来两个月零20多天吧才给我一审结果,还好是小修,总共3个审稿人。开心的是第二个审稿人夸我,说我做得好,肯定了我的工作。修回后过了20天,二审结果又是小修,但是没有意见,我懵了,只有第一审稿人说我回答的不错。发邮件问还有意见吗也不回我,害我白白等了10天多。后来自己随便改了下,一点点。第二天就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms亦菲, createdTime=Sun Apr 23 14:47:39 CST 2023, time=2023-04-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2160190, encodeId=1b8121601900c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:单体<br>经验分享:05-Mar-2023 投稿<br>08-Mar-2023 Under review(此under review是指送审)<br>15-Apr-2023 大修;5个审稿人,然后editor会统一发31条意见(40天,30个工作日,一审回来,此期刊不管大修还是小修都是3个月)<br>12-Jul-2023返修回去(中间经历毕业答辩,考试,所以花了3个月时间,但是如果修改的快的话,是不需要这么久的)<br>20-Aug-2023 小修意见回来(一个月左右),一个问题+润色,语言要求较高,会推荐wiley edit润色服务,但我没润色)<br>08-Sep-2023意见回来(因为上面叫润色,没润,然后老老实实润色)<br>润色完,返修回去,第二天接受<br>总体来说,期刊友好,审稿和送审速度都还行,审稿严谨仔细(包括参考文献都会仔细检查是否引用正确),wb结果审稿人会要求提供,可OA与非OA,物美价廉,是个不错的期刊。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b518121154, createdName=科研民工@, createdTime=Thu Sep 28 14:39:47 CST 2023, time=2023-09-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140923, encodeId=e1c62140923b4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:08-Nov-2022提交;17-Feb-2023返回大修;期间两次小修;Accept (03-Jun-2023)。4个审稿人,1个编辑(第二个高级编辑)提问。对语言要求较高,小修都是语言润色,建议提前润色可以缩短1-2个月审稿时间。杂志水平挺不错的,严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec4f6416632, createdName=ms8000000153643625, createdTime=Mon Jun 05 17:23:46 CST 2023, time=2023-06-05, status=1, ipAttribution=山西省)]
    2023-08-09 fireflysky6 来自湖北省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤药理
    经验分享:submitted: april 25, 2023
    final revisions submitted: july 20, 2023
    accepted: august 6, 2023
    第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。
    第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。
    8月9日发邮件确认license agreement,开始in production,有doi号。

    10

    展开10条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2198860, encodeId=1f2b219886031, content=请问接收后大概多长时间见刊呀?都两个半月了,还没任何动静。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c045428867, createdName=ms6000001777595875, createdTime=Tue Apr 16 21:26:35 CST 2024, time=2024-04-16, status=1, ipAttribution=孟加拉), GetPortalCommentsPageByObjectIdResponse(id=2199397, encodeId=1ebd219939eb5, content=审稿速度:24.0<br>经验分享:垃圾期刊,没有之一。投了七个多月了,没有任何消息,催搞也不回信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f32309374, createdName=1222328fm20(暂无昵称), createdTime=Sat Apr 20 00:04:12 CST 2024, time=2024-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195236, encodeId=d2ba21952361c, content=我想问一下大家编辑的31条意见应该怎么回复啊,需要每条很仔细的回复吗?还是应该怎么回复啊··, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=27625535846, createdName=ms4000001250091268, createdTime=Mon Mar 25 15:18:41 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126735, encodeId=79ad2126e355b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:感觉杂志水平很好,投稿过程较顺利,投稿1个月后大修,补实验1个月,提交后1个月后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf345468059, createdName=王明强, createdTime=Tue Apr 18 13:19:28 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184848, encodeId=352621848482f, content=请问in production状态消失了,还没有收到proof,也没有DIO号,后面还有啥流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b73f6470340, createdName=ms4000000369825251, createdTime=Tue Jan 30 16:54:01 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2127833, encodeId=4617212e8331b, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药;神经<br>经验分享:历时四个月左右文章才接受。之前投其他被拒绝了就不算了,真是漫长啊。幸运的是还好赶在了毕业答辩前。这个期刊发文量低得很,审稿漫长,大家着急的就不要投了。<br>提交3天后这个PHYTOTHER RES就under review 后来两个月零20多天吧才给我一审结果,还好是小修,总共3个审稿人。开心的是第二个审稿人夸我,说我做得好,肯定了我的工作。修回后过了20天,二审结果又是小修,但是没有意见,我懵了,只有第一审稿人说我回答的不错。发邮件问还有意见吗也不回我,害我白白等了10天多。后来自己随便改了下,一点点。第二天就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms亦菲, createdTime=Sun Apr 23 14:47:39 CST 2023, time=2023-04-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2160190, encodeId=1b8121601900c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:单体<br>经验分享:05-Mar-2023 投稿<br>08-Mar-2023 Under review(此under review是指送审)<br>15-Apr-2023 大修;5个审稿人,然后editor会统一发31条意见(40天,30个工作日,一审回来,此期刊不管大修还是小修都是3个月)<br>12-Jul-2023返修回去(中间经历毕业答辩,考试,所以花了3个月时间,但是如果修改的快的话,是不需要这么久的)<br>20-Aug-2023 小修意见回来(一个月左右),一个问题+润色,语言要求较高,会推荐wiley edit润色服务,但我没润色)<br>08-Sep-2023意见回来(因为上面叫润色,没润,然后老老实实润色)<br>润色完,返修回去,第二天接受<br>总体来说,期刊友好,审稿和送审速度都还行,审稿严谨仔细(包括参考文献都会仔细检查是否引用正确),wb结果审稿人会要求提供,可OA与非OA,物美价廉,是个不错的期刊。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b518121154, createdName=科研民工@, createdTime=Thu Sep 28 14:39:47 CST 2023, time=2023-09-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140923, encodeId=e1c62140923b4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:08-Nov-2022提交;17-Feb-2023返回大修;期间两次小修;Accept (03-Jun-2023)。4个审稿人,1个编辑(第二个高级编辑)提问。对语言要求较高,小修都是语言润色,建议提前润色可以缩短1-2个月审稿时间。杂志水平挺不错的,严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec4f6416632, createdName=ms8000000153643625, createdTime=Mon Jun 05 17:23:46 CST 2023, time=2023-06-05, status=1, ipAttribution=山西省)]
    2023-04-23 ms亦菲 来自江西省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:中药;神经
    经验分享:历时四个月左右文章才接受。之前投其他被拒绝了就不算了,真是漫长啊。幸运的是还好赶在了毕业答辩前。这个期刊发文量低得很,审稿漫长,大家着急的就不要投了。
    提交3天后这个PHYTOTHER RES就under review 后来两个月零20多天吧才给我一审结果,还好是小修,总共3个审稿人。开心的是第二个审稿人夸我,说我做得好,肯定了我的工作。修回后过了20天,二审结果又是小修,但是没有意见,我懵了,只有第一审稿人说我回答的不错。发邮件问还有意见吗也不回我,害我白白等了10天多。后来自己随便改了下,一点点。第二天就接受了。

    4

    展开4条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2198860, encodeId=1f2b219886031, content=请问接收后大概多长时间见刊呀?都两个半月了,还没任何动静。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c045428867, createdName=ms6000001777595875, createdTime=Tue Apr 16 21:26:35 CST 2024, time=2024-04-16, status=1, ipAttribution=孟加拉), GetPortalCommentsPageByObjectIdResponse(id=2199397, encodeId=1ebd219939eb5, content=审稿速度:24.0<br>经验分享:垃圾期刊,没有之一。投了七个多月了,没有任何消息,催搞也不回信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f32309374, createdName=1222328fm20(暂无昵称), createdTime=Sat Apr 20 00:04:12 CST 2024, time=2024-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195236, encodeId=d2ba21952361c, content=我想问一下大家编辑的31条意见应该怎么回复啊,需要每条很仔细的回复吗?还是应该怎么回复啊··, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=27625535846, createdName=ms4000001250091268, createdTime=Mon Mar 25 15:18:41 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126735, encodeId=79ad2126e355b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:感觉杂志水平很好,投稿过程较顺利,投稿1个月后大修,补实验1个月,提交后1个月后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf345468059, createdName=王明强, createdTime=Tue Apr 18 13:19:28 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184848, encodeId=352621848482f, content=请问in production状态消失了,还没有收到proof,也没有DIO号,后面还有啥流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b73f6470340, createdName=ms4000000369825251, createdTime=Tue Jan 30 16:54:01 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2127833, encodeId=4617212e8331b, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药;神经<br>经验分享:历时四个月左右文章才接受。之前投其他被拒绝了就不算了,真是漫长啊。幸运的是还好赶在了毕业答辩前。这个期刊发文量低得很,审稿漫长,大家着急的就不要投了。<br>提交3天后这个PHYTOTHER RES就under review 后来两个月零20多天吧才给我一审结果,还好是小修,总共3个审稿人。开心的是第二个审稿人夸我,说我做得好,肯定了我的工作。修回后过了20天,二审结果又是小修,但是没有意见,我懵了,只有第一审稿人说我回答的不错。发邮件问还有意见吗也不回我,害我白白等了10天多。后来自己随便改了下,一点点。第二天就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms亦菲, createdTime=Sun Apr 23 14:47:39 CST 2023, time=2023-04-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2160190, encodeId=1b8121601900c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:单体<br>经验分享:05-Mar-2023 投稿<br>08-Mar-2023 Under review(此under review是指送审)<br>15-Apr-2023 大修;5个审稿人,然后editor会统一发31条意见(40天,30个工作日,一审回来,此期刊不管大修还是小修都是3个月)<br>12-Jul-2023返修回去(中间经历毕业答辩,考试,所以花了3个月时间,但是如果修改的快的话,是不需要这么久的)<br>20-Aug-2023 小修意见回来(一个月左右),一个问题+润色,语言要求较高,会推荐wiley edit润色服务,但我没润色)<br>08-Sep-2023意见回来(因为上面叫润色,没润,然后老老实实润色)<br>润色完,返修回去,第二天接受<br>总体来说,期刊友好,审稿和送审速度都还行,审稿严谨仔细(包括参考文献都会仔细检查是否引用正确),wb结果审稿人会要求提供,可OA与非OA,物美价廉,是个不错的期刊。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b518121154, createdName=科研民工@, createdTime=Thu Sep 28 14:39:47 CST 2023, time=2023-09-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140923, encodeId=e1c62140923b4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:08-Nov-2022提交;17-Feb-2023返回大修;期间两次小修;Accept (03-Jun-2023)。4个审稿人,1个编辑(第二个高级编辑)提问。对语言要求较高,小修都是语言润色,建议提前润色可以缩短1-2个月审稿时间。杂志水平挺不错的,严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec4f6416632, createdName=ms8000000153643625, createdTime=Mon Jun 05 17:23:46 CST 2023, time=2023-06-05, status=1, ipAttribution=山西省)]
    2023-09-28 科研民工@ 来自广东省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:单体
    经验分享:05-Mar-2023 投稿
    08-Mar-2023 Under review(此under review是指送审)
    15-Apr-2023 大修;5个审稿人,然后editor会统一发31条意见(40天,30个工作日,一审回来,此期刊不管大修还是小修都是3个月)
    12-Jul-2023返修回去(中间经历毕业答辩,考试,所以花了3个月时间,但是如果修改的快的话,是不需要这么久的)
    20-Aug-2023 小修意见回来(一个月左右),一个问题+润色,语言要求较高,会推荐wiley edit润色服务,但我没润色)
    08-Sep-2023意见回来(因为上面叫润色,没润,然后老老实实润色)
    润色完,返修回去,第二天接受
    总体来说,期刊友好,审稿和送审速度都还行,审稿严谨仔细(包括参考文献都会仔细检查是否引用正确),wb结果审稿人会要求提供,可OA与非OA,物美价廉,是个不错的期刊。


    8

    展开8条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2198860, encodeId=1f2b219886031, content=请问接收后大概多长时间见刊呀?都两个半月了,还没任何动静。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c045428867, createdName=ms6000001777595875, createdTime=Tue Apr 16 21:26:35 CST 2024, time=2024-04-16, status=1, ipAttribution=孟加拉), GetPortalCommentsPageByObjectIdResponse(id=2199397, encodeId=1ebd219939eb5, content=审稿速度:24.0<br>经验分享:垃圾期刊,没有之一。投了七个多月了,没有任何消息,催搞也不回信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8f32309374, createdName=1222328fm20(暂无昵称), createdTime=Sat Apr 20 00:04:12 CST 2024, time=2024-04-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2195236, encodeId=d2ba21952361c, content=我想问一下大家编辑的31条意见应该怎么回复啊,需要每条很仔细的回复吗?还是应该怎么回复啊··, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=27625535846, createdName=ms4000001250091268, createdTime=Mon Mar 25 15:18:41 CST 2024, time=2024-03-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2126735, encodeId=79ad2126e355b, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:感觉杂志水平很好,投稿过程较顺利,投稿1个月后大修,补实验1个月,提交后1个月后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf345468059, createdName=王明强, createdTime=Tue Apr 18 13:19:28 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2184848, encodeId=352621848482f, content=请问in production状态消失了,还没有收到proof,也没有DIO号,后面还有啥流程呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b73f6470340, createdName=ms4000000369825251, createdTime=Tue Jan 30 16:54:01 CST 2024, time=2024-01-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2127833, encodeId=4617212e8331b, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药;神经<br>经验分享:历时四个月左右文章才接受。之前投其他被拒绝了就不算了,真是漫长啊。幸运的是还好赶在了毕业答辩前。这个期刊发文量低得很,审稿漫长,大家着急的就不要投了。<br>提交3天后这个PHYTOTHER RES就under review 后来两个月零20多天吧才给我一审结果,还好是小修,总共3个审稿人。开心的是第二个审稿人夸我,说我做得好,肯定了我的工作。修回后过了20天,二审结果又是小修,但是没有意见,我懵了,只有第一审稿人说我回答的不错。发邮件问还有意见吗也不回我,害我白白等了10天多。后来自己随便改了下,一点点。第二天就接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e468439140, createdName=ms亦菲, createdTime=Sun Apr 23 14:47:39 CST 2023, time=2023-04-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2160190, encodeId=1b8121601900c, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:单体<br>经验分享:05-Mar-2023 投稿<br>08-Mar-2023 Under review(此under review是指送审)<br>15-Apr-2023 大修;5个审稿人,然后editor会统一发31条意见(40天,30个工作日,一审回来,此期刊不管大修还是小修都是3个月)<br>12-Jul-2023返修回去(中间经历毕业答辩,考试,所以花了3个月时间,但是如果修改的快的话,是不需要这么久的)<br>20-Aug-2023 小修意见回来(一个月左右),一个问题+润色,语言要求较高,会推荐wiley edit润色服务,但我没润色)<br>08-Sep-2023意见回来(因为上面叫润色,没润,然后老老实实润色)<br>润色完,返修回去,第二天接受<br>总体来说,期刊友好,审稿和送审速度都还行,审稿严谨仔细(包括参考文献都会仔细检查是否引用正确),wb结果审稿人会要求提供,可OA与非OA,物美价廉,是个不错的期刊。<br><br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b518121154, createdName=科研民工@, createdTime=Thu Sep 28 14:39:47 CST 2023, time=2023-09-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140923, encodeId=e1c62140923b4, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:08-Nov-2022提交;17-Feb-2023返回大修;期间两次小修;Accept (03-Jun-2023)。4个审稿人,1个编辑(第二个高级编辑)提问。对语言要求较高,小修都是语言润色,建议提前润色可以缩短1-2个月审稿时间。杂志水平挺不错的,严谨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec4f6416632, createdName=ms8000000153643625, createdTime=Mon Jun 05 17:23:46 CST 2023, time=2023-06-05, status=1, ipAttribution=山西省)]
    2023-06-05 ms8000000153643625 来自山西省

    审稿速度:12.0 | 投稿命中率:50.0
    偏重的研究方向:中药单体;药理机制
    经验分享:08-Nov-2022提交;17-Feb-2023返回大修;期间两次小修;Accept (03-Jun-2023)。4个审稿人,1个编辑(第二个高级编辑)提问。对语言要求较高,小修都是语言润色,建议提前润色可以缩短1-2个月审稿时间。杂志水平挺不错的,严谨。

    2

    展开2条回复
共304条页码: 1/31页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分